RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Constitutively active signaling pathways involving Ras, Raf, and Fos oncogenes are implicated in numerous cancers.
• Cell transformation, a hallmark of cancer, is often driven by altered gene expression patterns.

Purpose of the Study:

• To identify common and distinct transcriptional targets of Ras, Raf, and Fos oncogenes in transformed cells.
• To investigate the potential of TGF-beta to reverse oncogene-induced gene expression changes and cellular transformation.

Main Methods:

• Gene expression profiling was employed to analyze 3T3 cells transformed by Ras, Raf, and Fos.
• Gene expression profiling was also used to assess the TGF-beta response in fibroblasts.

Main Results:

• Transcriptional repression of extracellular matrix (ECM) genes emerged as a conserved feature of oncogene-induced cell transformation.
• TGF-beta treatment selectively reversed gene expression changes related to ECM and cytoskeleton components in transformed cells.
• This selective reversal correlated with a partial restoration of the transformed cell phenotype.

Conclusions:

• The Ras/Raf/ERK signaling pathway's repression of specific genes is linked to the transformed phenotype.
• TGF-beta signaling can counteract oncogene-induced gene expression changes, particularly those affecting ECM and cytoskeleton.
• A significant correlation exists between signaling pathway activity, gene expression modulation, and the transformed fibroblast phenotype.